Announced
Completed
HBM Healthcare Investments and Samsara BioCapital led a $36m series A financing round in Mineralys Therapeutics.
Financials
Transaction Value£25m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
Domestic
Private Equity
Private
Minority
Friendly
life sciences
United States
Venture Capital
Completed
Biotechnology
Acquisition
Synopsis
HBM Healthcare Investments and Samsara BioCapital, two venture capital firms, led a $36m series A financing round in Mineralys Therapeutics, an American biotech firm.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.